{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T21:17:45Z","timestamp":1777929465576,"version":"3.51.4"},"reference-count":15,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2020,9,10]],"date-time":"2020-09-10T00:00:00Z","timestamp":1599696000000},"content-version":"unspecified","delay-in-days":9,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Gastroenterol"],"accepted":{"date-parts":[[2020,8,19]]},"published-print":{"date-parts":[[2020,9]]},"abstract":"<jats:p>Nivolumab is an immune checkpoint inhibitor used to treat multiple solid-organ malignancies. While many of its immune-related adverse events are well established, nivolumab-induced sclerosing cholangitis remains poorly characterised, with no defined diagnostic criteria. Moreover, data regarding long-term outcomes are particularly lacking. We present a biopsy-proven case of nivolumab-induced sclerosing cholangitis, which uniquely captures 18 months of follow-up post-treatment. Our case highlights key features of intrahepatic subtype sclerosing cholangitis and suggests durable response to corticosteroid therapy.<\/jats:p>","DOI":"10.1136\/bmjgast-2020-000487","type":"journal-article","created":{"date-parts":[[2020,9,11]],"date-time":"2020-09-11T02:25:58Z","timestamp":1599791158000},"page":"e000487","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":17,"title":["Case of nivolumab-induced sclerosing cholangitis: lessons from long-term follow-up"],"prefix":"10.1136","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2810-7443","authenticated-orcid":false,"given":"Tess","family":"McClure","sequence":"first","affiliation":[{"name":"Gastroenterology, Austin Health, Heidelberg, Victoria, Australia"},{"name":"Medicine, The University of Melbourne, Melbourne, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wanyuan","family":"Cui","sequence":"additional","affiliation":[{"name":"Medicine, The University of Melbourne, Melbourne, Victoria, Australia"},{"name":"Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khashayar","family":"Asadi","sequence":"additional","affiliation":[{"name":"Anatomical Pathology, Austin Health, Heidelberg, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"John","sequence":"additional","affiliation":[{"name":"Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam","family":"Testro","sequence":"additional","affiliation":[{"name":"Gastroenterology, Austin Health, Heidelberg, Victoria, Australia"},{"name":"Medicine, The University of Melbourne, Melbourne, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2020,9,10]]},"reference":[{"key":"2025073013260170000_7.1.e000487.1","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-019-0116-x"},{"key":"2025073013260170000_7.1.e000487.2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1507643"},{"key":"2025073013260170000_7.1.e000487.3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)32409-7"},{"key":"2025073013260170000_7.1.e000487.4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1200690"},{"key":"2025073013260170000_7.1.e000487.5","doi-asserted-by":"crossref","first-page":"353","DOI":"10.3748\/wjg.v26.i3.353","article-title":"Programmed cell death-1 inhibitor-related sclerosing cholangitis: a systematic review","volume":"26","author":"Onoyama","year":"2020","journal-title":"World J Gastroenterol"},{"key":"2025073013260170000_7.1.e000487.6","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1093\/annonc\/mdw649","article-title":"Nivolumab-induced cholangitic liver disease: a novel form of serious liver injury","volume":"28","author":"Gelsomino","year":"2017","journal-title":"Ann Oncol"},{"key":"2025073013260170000_7.1.e000487.7","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s10637-017-0453-0","article-title":"Imaging and clinicopathological features of nivolumab-related cholangitis in patients with non-small cell lung cancer","volume":"35","author":"Kawakami","year":"2017","journal-title":"Invest New Drugs"},{"key":"2025073013260170000_7.1.e000487.8","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdy162"},{"key":"2025073013260170000_7.1.e000487.9","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pathol-020712-164014"},{"key":"2025073013260170000_7.1.e000487.10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199504063321406"},{"key":"2025073013260170000_7.1.e000487.11","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1055\/s-2007-1007354","article-title":"Disappearing intrahepatic bile ducts: the syndromes and their mechanisms","volume":"13","author":"Woolf","year":"1993","journal-title":"Semin Liver Dis"},{"key":"2025073013260170000_7.1.e000487.12","doi-asserted-by":"publisher","DOI":"10.1016\/0270-9139(95)90246-5"},{"key":"2025073013260170000_7.1.e000487.13","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/0016-5085(90)90839-S","article-title":"A shared and unique epitope(s) on human colon, skin, and biliary epithelium detected by a monoclonal antibody","volume":"98","author":"Das","year":"1990","journal-title":"Gastroenterology"},{"key":"2025073013260170000_7.1.e000487.14","first-page":"893","article-title":"Immunogenetic aspects of primary sclerosing cholangitis: implications for therapeutic strategies","volume":"90","author":"van Milligen de Wit","year":"1995","journal-title":"Am J Gastroenterol"},{"key":"2025073013260170000_7.1.e000487.15","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/MOG.0000000000000334","article-title":"Intestinal microbiota in primary sclerosing cholangitis","volume":"33","author":"Hov","year":"2017","journal-title":"Curr Opin Gastroenterol"}],"container-title":["BMJ Open Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjgast-2020-000487","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T20:26:09Z","timestamp":1753907169000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopengastro.bmj.com\/lookup\/doi\/10.1136\/bmjgast-2020-000487"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":15,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,9,10]]},"published-print":{"date-parts":[[2020,9]]}},"alternative-id":["10.1136\/bmjgast-2020-000487"],"URL":"https:\/\/doi.org\/10.1136\/bmjgast-2020-000487","relation":{},"ISSN":["2054-4774"],"issn-type":[{"value":"2054-4774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9]]}}}